A major goal should be to identify compounds targeting MMP13 without interfering with other MMPs, not only for the previously suggested treatment of joint diseases (Takaishi et al, 2008), but as shown by our data also for the treatment of pathologies such as sepsis and IBD. The gene discussed is MMP13; the disease is inflammatory bowel disease.